Kubak B M, Potempa L A, Anderson B, Mahklouf S, Venegas M, Gewurz H, Gewurz A T
Department of Immunology/Microbiology, Rush Medical College, Chicago, IL 60612.
Mol Immunol. 1988 Sep;25(9):851-8. doi: 10.1016/0161-5890(88)90121-6.
Serum amyloid P component (SAP) is a normal human serum protein with pentraxin structure that has morphological and immunochemical identity to the amyloid P component found in normal tissue and amyloid deposits. In the presence of calcium, SAP binds to certain complex polysaccharides, including agarose and zymosan. While the binding of SAP to agarose involves interaction with a galactose pyruvate acetal, the ligand in zymosan has not been defined. In the present study we determined that SAP binds to ligand(s) in a soluble extract of zymosan prepared by alkaline hydrolysis, which contains the mannose oligosaccharide sequences alpha DMan1----3DMan and alpha DMan1----6DMan. SAP did not bind to the alkali-insoluble fraction of zymosan, which is predominantly a glucan polymer, and its binding to zymosan extract which had been absorbed with concanavalin A was markedly reduced, suggesting that mannose residues are involved in the binding of SAP to zymosan. We also demonstrated that SAP binds to the glycoproteins ovalbumin, thyroglobulin, beta-glucuronidase and C3bi, which contain mannose-terminated sequences, while it did not bind to native and desialized preparations of ovomucoid, alpha 1-acid glycoprotein and glycophorin, which lack terminal mannose residues. SAP did not bind to pneumococcal C polysaccharide or to N-acetylglucosamine oligosaccharides covalently linked to a protein carrier. The binding of SAP to ligand(s) in zymosan extract or ovalbumin was inhibited by the preincubation of SAP with either zymosan extract or ovalbumin glycopeptides, both of which share similar mannose oligosaccharide sequences. All of the SAP binding reactions required calcium, were maximal at approximately 1 mM calcium, and gave similar results whether purified SAP or SAP in serum was used. These findings indicate that mannose-terminated oligosaccharides of polysaccharides and glycoproteins represent a new class of ligands for SAP and suggest that SAP may function as a mannose-binding protein.
血清淀粉样蛋白P成分(SAP)是一种具有五聚体结构的正常人血清蛋白,与正常组织和淀粉样沉积物中发现的淀粉样蛋白P成分在形态学和免疫化学上具有一致性。在有钙存在的情况下,SAP可与某些复合多糖结合,包括琼脂糖和酵母聚糖。虽然SAP与琼脂糖的结合涉及与半乳糖丙酮酸缩醛的相互作用,但酵母聚糖中的配体尚未明确。在本研究中,我们确定SAP可与经碱性水解制备的酵母聚糖可溶性提取物中的配体结合,该提取物含有甘露糖寡糖序列α-DMan1→3DMan和α-DMan1→6DMan。SAP不与酵母聚糖的碱不溶性部分结合,该部分主要是葡聚糖聚合物,并且其与已用伴刀豆球蛋白A吸附的酵母聚糖提取物的结合明显减少,这表明甘露糖残基参与了SAP与酵母聚糖的结合。我们还证明,SAP可与含有甘露糖末端序列的糖蛋白卵清蛋白、甲状腺球蛋白、β-葡萄糖醛酸酶和C3bi结合,而不与缺乏末端甘露糖残基的卵类粘蛋白、α1-酸性糖蛋白和血型糖蛋白的天然及去唾液酸化制剂结合。SAP不与肺炎球菌C多糖或与蛋白质载体共价连接的N-乙酰葡糖胺寡糖结合。预先将SAP与酵母聚糖提取物或卵清蛋白糖肽一起温育可抑制SAP与酵母聚糖提取物或卵清蛋白中配体的结合,这两者都具有相似的甘露糖寡糖序列。所有的SAP结合反应都需要钙,在约1 mM钙时达到最大值,并且无论使用纯化的SAP还是血清中的SAP都得到相似的结果。这些发现表明多糖和糖蛋白的甘露糖末端寡糖代表了SAP的一类新配体,并提示SAP可能作为一种甘露糖结合蛋白发挥作用。